اگلا

آٹو پلے

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 مناظر • 07/14/23
بانٹیں
ایمبیڈ
administrator
administrator
سبسکرائبرز
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

مزید دکھائیں
0 تبصرے sort ترتیب دیں
فیس بک کے تبصرے

اگلا

آٹو پلے